ADAM10 and acute lymphoblastic leukemia: Consistent with ADAM10 mRNA findings, CD58 expression in untreated Chronic Lymphocytic Leukemia (CLL) cases remained statistically non-significant, and no significant differences were observed between treated ALL groups and controls, or between ALL and CLL groups.